Greater Glasgow and Clyde Medicines
Key to symbols The medicine should be initiated by, or on the advice of a specialist, but is suitable for continuation by a GP The medicine should only be used and prescribed by a specialist Indicates the preferred choice within a class or group of medicines
The medicine should be initiated by, or on the advice of a specialist, but is suitable for continuation by a GP
The medicine should only be used and prescribed by a specialist
Indicates the preferred choice within a class or group of medicines
11.8. Miscellaneous ophthalmic preparations

11.8.1. Tear deficiency, ocular lubricants, and astringents

Patients with chronic dry eye conditions should be educated that long-term and regular use of eye lubricants is recommended to achieve maximum benefit. Many of the preparations for dry eyes are considered to be medical devices rather than medicines. The preparations listed in this section are all included in Part 3 of the Scottish Drug Tariff (Appliances) and are able to be prescribed on a GP10 prescription.

 

In November 2023 the MHRA issued a safety alert for use of certain carbomer eye drops. This has now been widened to a safety alert for all carbomer eye drops in certain patient groups click here

11.8.1.1. Carbomer-based preparations

Preferred List
Preferred List First Line
CLINITAS GEL (EYE DROPS)

Prescribing Notes:

  • Clinitas gel is considered the first line treatment for dry eye conditions. 
  • Contains carbomer 980 0.2% as the active ingredient. 
  • Preservatives: cetrimide, sodium edetate.

In November 2023 the MHRA issued a safety alert for use of certain carbomer eye drops. This has now been widened to a safety alert for all carbomer eye drops in certain patient groups click here

BNF Link

LUMECARE (eye gel)

Prescribing Notes:

  • Contains carbomer 0.2%. 
  • Preservatives: cetrimide, disodium edetate

In November 2023 the MHRA issued a safety alert for use of certain carbomer eye drops. This has now been widened to a safety alert for all carbomer eye drops in certain patient groups click here

BNF Link

11.8.1.2. Paraffin-based preparations

Preferred List
Hylo-Night (ointment)

Prescribing Notes:

  • Hylo-Night is the preferred paraffin-based preparation and until recently was known as VITA-POS.
  • The recommended frequency is once daily at night.
  • Contains retinol palmitate 259units/g, liquid paraffin and wool fat. 
  • Preservatives: preservative-free.

BNF Link

Xailin Night (eye ointment)

Prescribing Notes:

  • Contains white soft paraffin, white mineral oil and lanolin alcohols. 
  • Preservatives: preservative-free.

BNF Link

11.8.1.3. Sodium hyaluronate preparations

Total Formulary
Total Formulary First Line
BLINK INTENSIVE TEARS (Eye drops)

Restrictions:

Restricted to use in severe dry eyes only.

Prescribing Notes:

  • Considered the first line sodium hyaluronate preparation.
  • Contains sodium hyaluronate 0.2%, polyethylene glycol 0.25%. 
  • Preservatives: borax, boric acid.

BNF Link

EYEAZE (0.4% eye drops)

Restrictions:

Restricted to use in severe dry eye only.

Prescribing Notes:

  • This preparation should be considered for patients with dexterity problems and for whom this administration system is suitable.
  • Contains sodium hyaluronate 
  • Preservatives: preservative-free.

BNF Link

THEALOZ DUO (eye drops)

Restrictions:

Restricted to use in severe dry eyes when Blink Intensive Tears or Eyeaze are not appropriate and the addition of trehalose is desirable (corneal damage).

Prescribing Notes:

  • Contains sodium hyaluronate (0.15%) and trehalose (3%)
  • Preservatives: preservative-free

BNF Link

11.8.1.4. Carmellose-based preparations

Total Formulary
EVOLVE CARMELLOSE (eye drops)

Restrictions:

Restricted to use in severe dry eyes only.

Prescribing Notes:

  • Contains carmellose sodium 0.5%
  • Preservatives: boric acid

BNF Link

CELLUVISC (0.5% eye drops)

Restrictions:

Restricted to use in severe dry eyes only.

Prescribing Notes:

  • Single dose units contain carmellose sodium 0.5%. 
  • Preservatives: preservative-free.

BNF Link

11.8.1.5. Other ocular lubricant preparations

Total Formulary
Specialist and GP
CICLOSPORIN (IKERVIS) (eye drops)

Restrictions:

Restricted to initiation by consultant ophthalmologists for the treatment of severe keratitis in adults with dry eye disease which has not improved despite treatment with tear substitutes.

BNF Link

HYPROMELLOSE (eye drops)

Restrictions:

Excludes single dose unit preparations.

Prescribing Notes:

Use for short-term management of simple dry-eye. Other treatment options may be more appropriate for chronic dry eyes. 

Contains hypromellose 0.3%. Preservatives may include benzalkonium chloride. 

BNF Link

Specialist and GP
ILUBE (Eye drops)

Restrictions:

Restricted to initiation by specialist for use in severe dry eyes only.

Prescribing Notes:

  • Contains acetylcysteine 5% and hypromellose 0.35%
  • Preservatives: benzalkonium chloride, disodium edetate

BNF Link

SYSTANE BALANCE (EYE DROPS)

Restrictions:

Restricted to use in severe dry eyes only.

Prescribing Notes:

  • Do not use more than four times daily
  • Contains polyglycol 0.3% and polyethylene glycol 400 0.4%
  • Preservatives: boric acid, disodium edetate

BNF Link